Lamotrigine: neuroprotective effect in rats after kainic acid induced seizures
Dinko Vitezić, Jasenka Mršić‐Pelčić, Gordana Župan, Dubravka Šepić Grahovac, Ante Simonić
Abstract
Dinko Vitezić, Jasenka Mršić‐Pelčić, Gordana Župan, Dubravka Šepić Grahovac, Ante Simonić
Abstract
Purpose: Kainic acid (KA) is used as an experimental agent which produces convulsions and neurotoxic lesions. We examined the effects of KA induced convulsions on the activity of Na+, K+- ATPase, activation of JNK/c-jun axis and histological changes in rat hippocampus. Lamotrigine (LTG) is an antiepileptic drug, a glutamate release inhibitor, with action at the neuronal voltage-gated sodium channel. Therefore, this study was also designed to investigate the influence of LTG pre-treatment on the mentioned hippocampal changes. Methods: The study was carried out on Hanover-Wistar rats. Na+, K+- ATPase activity from hippocampal tissue was determined two hours, three days and five days after a single subcutaneous KA (8 mg/kg) injection. The inductions of JNK/c-jun and hippocampal histological changes were determined two hours and five days after KA application. LTG (30 mg/kg i.p.) was used two hours before KA application and for five consecutive days. Results: After KA application, Na+, K+- ATPase activity was significantly inhibited and the induction of JNK/c-jun axis was observed. The number of hippocampal CA1 cells was significantly lower in all groups of the rats treated with KA. In the group of LTG pre-treated rats Na+, K+- ATPase inhibition, and JNK/c-jun induction were detected the fifth day after KA treatment, but the inhibition of Na+, K+- ATPase was significantly less pronounced. The number of damaged cells was significantly less in LTG pre-treated rats. Conclusion: Systemic application of KA showed statistically significant changes in the evaluated parameters in the rats' hippocampi. LTG pre-treatment has a partially neuroprotective effect in KA-treated animals.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Purpose: Kainic acid (KA) is used as an experimental agent which produces convulsions and neurotoxic lesions. We examined the effects of KA induced convulsions on the activity of Na+, K+- ATPase, activation of JNK/c-jun axis and histological changes in rat hippocampus. Lamotrigine (LTG) is an antiepileptic drug, a glutamate release inhibitor, with action at the neuronal voltage-gated sodium channel. Therefore, this study was also designed to investigate the influence of LTG pre-treatment on the mentioned hippocampal changes. Methods: The study was carried out on Hanover-Wistar rats. Na+, K+- ATPase activity from hippocampal tissue was determined two hours, three days and five days after a single subcutaneous KA (8 mg/kg) injection. The inductions of JNK/c-jun and hippocampal histological changes were determined two hours and five days after KA application. LTG (30 mg/kg i.p.) was used two hours before KA application and for five consecutive days. Results: After KA application, Na+, K+- ATPase activity was significantly inhibited and the induction of JNK/c-jun axis was observed. The number of hippocampal CA1 cells was significantly lower in all groups of the rats treated with KA. In the group of LTG pre-treated rats Na+, K+- ATPase inhibition, and JNK/c-jun induction were detected the fifth day after KA treatment, but the inhibition of Na+, K+- ATPase was significantly less pronounced. The number of damaged cells was significantly less in LTG pre-treated rats. Conclusion: Systemic application of KA showed statistically significant changes in the evaluated parameters in the rats' hippocampi. LTG pre-treatment has a partially neuroprotective effect in KA-treated animals.
Key concepts: Kainic acid, Hippocampal formation, Lamotrigine, Hippocampus, Pharmacology, Glutamate receptor, Chemistry, Internal medicine